Fiera Capital Corp Vertex Pharmaceuticals Inc Transaction History

Fiera Capital Corp

$30.4 Billion
Q2 2024

A detailed history of Fiera Capital Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fiera Capital Corp holds 8,997 shares of VRTX stock, worth $4.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,997

Previous 8,997 -0.0%

Holding current value

$4.27 Million

Previous $4.22 Million -0.0%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$392.81 - $485.53 $276,931 - $342,298	705 Added 8.5%	8,997 $4.22 Million
Q1 2024 Aug 22, 2024	SELL	$407.69 - $446.08 $287,421 - $314,486	-705 Reduced 7.84%	8,292 $3.47 Million
Q1 2024 May 01, 2024	SELL	$407.69 - $446.08 $1.01 Million - $1.1 Million	-2,468 Reduced 22.94%	8,292 $3.47 Million
Q4 2023 Aug 22, 2024	SELL	$343.0 - $410.68 $33,271 - $39,835	-97 Reduced 0.89%	10,760 $4.38 Million
Q4 2023 Feb 08, 2024	SELL	$343.0 - $410.68 $33,271 - $39,835	-97 Reduced 0.89%	10,760 $4.38 Million
Q3 2023 Aug 22, 2024	BUY	$338.18 - $362.46 $629,014 - $674,175	1,860 Added 20.67%	10,857 $3.78 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $95,028 - $101,851	281 Added 2.66%	10,857 $3.78 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $90,238 - $100,998	-287 Reduced 2.64%	10,576 $3.72 Million
Q1 2023 Apr 26, 2023	SELL	$283.23 - $323.1 $13,595 - $15,508	-48 Reduced 0.44%	10,863 $3.42 Million
Q4 2022 Feb 08, 2023	SELL	$285.76 - $321.48 $20,003 - $22,503	-70 Reduced 0.64%	10,911 $3.15 Million
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $751,663 - $838,679	2,745 Added 33.33%	10,981 $2.93 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $2.74 Million - $3.42 Million	-11,680 Reduced 58.65%	8,236 $2.32 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $3.72 Million - $4.39 Million	16,823 Added 543.91%	19,916 $5.2 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $547,491 - $691,130	3,093 New	3,093 $680,000
Q1 2019 May 10, 2019	SELL	$163.73 - $194.7 $496,265 - $590,135	-3,031 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $6,532 - $8,265	-43 Reduced 1.4%	3,031 $502,000
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $81,013 - $93,093	483 Added 18.64%	3,074 $592,000
Q2 2018 Aug 02, 2018	BUY	$145.72 - $169.96 $42,550 - $49,628	292 Added 12.7%	2,591 $440,000
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $32,745 - $38,260	216 Added 10.37%	2,299 $375,000
Q4 2017 Feb 09, 2018	SELL	$137.28 - $155.55 $2,882 - $3,266	-21 Reduced 1.0%	2,083 $312,000
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $311,665 - $341,352	2,104	2,104 $320,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Vertex Pharmaceuticals Inc Transaction History